Cargando…

Precision Therapy for Mesothelioma: Feasibility and New Opportunities

SIMPLE SUMMARY: Mesothelioma remains a lethal cancer. Personalized treatment is lacking. Emerging insights into the genomic and epigenomic landscape of mesothelioma highlight promising opportunities for precision therapy, where are discussed. ABSTRACT: Malignant pleural mesotheliomas (MPMs) are char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dulloo, Sean, Bzura, Aleksandra, Fennell, Dean Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152279/ https://www.ncbi.nlm.nih.gov/pubmed/34067960 http://dx.doi.org/10.3390/cancers13102347

Ejemplares similares

Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres
por: Fennell, Dean, et al.
Publicado: (2023)

BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms
por: Singh, Anita, et al.
Publicado: (2022)

The opportunity in African genome resource for precision medicine
por: Fatumo, Segun
Publicado: (2020)

Big Data in radiation therapy: challenges and opportunities
por: Lustberg, Tim, et al.
Publicado: (2017)

Splicing molecular biology and novel therapies in diffuse malignant peritoneal mesothelioma
por: Napolitano, Andrea
Publicado: (2019)

Mesothelioma: Hippo pathway as a target, lessons from COMMAND
por: Fennell, Dean A., et al.
Publicado: (2019)

Malignant Mesothelioma and Delivery of Polyphenols
por: Bishop, Karen S., et al.
Publicado: (2016)

Adipose Tissue Plasticity in Catch-Up–Growth Trajectories to Metabolic Syndrome: Hyperplastic Versus Hypertrophic Catch-Up Fat
por: Dulloo, Abdul G.
Publicado: (2009)

Of new times, new opportunities, and old problems
por: van der Lei, Johan, et al.
Publicado: (2007)

Precision nomenclature for the new genomics
por: Lewin, Harris A, et al.
Publicado: (2019)

An appropriate choice for immunotherapy in malignant pleural mesothelioma
por: Fujimoto, Nobukazu
Publicado: (2020)

Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
por: Prasanna, Pataje G, et al.
Publicado: (2021)

Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
por: Harber, James, et al.
Publicado: (2021)

New challenges and opportunities for industrial biotechnology
por: Chen, Guo-Qiang
Publicado: (2012)

Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016)

Commentary: When cancer is oligometastatic, even mesothelioma is curable
por: Abbas, Abbas E.
Publicado: (2020)

Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology
por: Meirson, Tomer, et al.
Publicado: (2022)

Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
por: Zhang, Min, et al.
Publicado: (2021)

New paradigms in cervical cancer prevention: opportunities and risks
por: Ronco, Guglielmo, et al.
Publicado: (2008)

Refining precision cancer therapy in ALK-positive NSCLC
por: Lin, Jessica J., et al.
Publicado: (2019)

“Precision” Medicine in Membranous Nephropathy: Serology-Guided Therapy
por: Glassock, Richard J., et al.
Publicado: (2023)

Not so WEE: Targeting G(2)/M to kill mesothelioma cells
por: Dent, Paul
Publicado: (2014)

Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma
por: Pinton, Giulia, et al.
Publicado: (2017)

Refining classification of malignant pleural mesothelioma reveals its Achilles’ heel
por: Pateras, Ioannis S.
Publicado: (2019)

Insulin Pump Therapy Training and Management: An Opportunity for Community Pharmacists
por: Boyd, LeAnn C., et al.
Publicado: (2008)

The 1000 Genomes Project: new opportunities for research and social challenges
por: Via, Marc, et al.
Publicado: (2010)

New opportunities in tuberculosis prevention: implications for people living with HIV
por: González Fernández, Lucia, et al.
Publicado: (2020)

Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
por: Zhang, Min, et al.
Publicado: (2021)

New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma
por: Rossini, Marika, et al.
Publicado: (2018)

The gas stove-childhood asthma kerfuffle: A teaching opportunity
por: Cox, Louis Anthony
Publicado: (2023)

World TB day: a new opportunity to reimagine workplace health
por: Reid, Michael, et al.
Publicado: (2021)

Windows of opportunity: a new tree-shrub dynamic at alpine treeline?
por: Elliott, Grant P
Publicado: (2023)

Vitamin D and Influenza—Prevention or Therapy?
por: Gruber-Bzura, Beata M.
Publicado: (2018)

COVID-19 presents opportunities and threats to transport and health
por: Laverty, Anthony A, et al.
Publicado: (2020)

Are We Facing a New Colposcopic Practice in the HPV Vaccination Era? Opportunities, Challenges, and New Perspectives
por: Lukic, Ankica, et al.
Publicado: (2021)

Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy
por: Bogetofte Barnkob, Mike, et al.
Publicado: (2022)

Silibinin: A New Opportunity for the Treatment of Brain Metastasis from Lung Cancer
por: Addeo, Raffaele
Publicado: (2021)

Pharmaco-omics data sheds light on therapy-oriented prospects of precision medicine
por: Zheng, Jie, et al.
Publicado: (2021)

Precision tuberculosis control by genome sequencing: Benefit and challenges of a new standard
por: Supply, Philip
Publicado: (2018)

Evolving Landscape of Initial Treatments for Patients with Malignant Pleural Mesotheliomas: Clinical Trials to Clinical Practice
por: Offin, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dm0bp15j4e7gtb8shogbvi0m60